BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20605005)

  • 1. [Long-term health insurance payments for depression in Germany - a secondary analysis of routine data].
    Stamm K; Reinhard I; Salize HJ
    Neuropsychiatr; 2010; 24(2):99-107. PubMed ID: 20605005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
    Stäbler W; Wagner B
    Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of decreasing sick leave benefits--results of a survey of Social Health Insurance members].
    Helmert U; Braun B; Beck R; Marstedt G; Müller R; Müller H; Hebel D
    Gesundheitswesen; 1997; 59(8-9):495-500. PubMed ID: 9440911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
    Stock SA; Redaelli M; Wendland G; Civello D; Lauterbach KW
    Diabet Med; 2006 Mar; 23(3):299-305. PubMed ID: 16492214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost of care for depressive disorders in primary and specialized care in Germany].
    Salize HJ; Stamm K; Schubert M; Bergmann F; Härter M; Berger M; Gaebel W; Schneider F
    Psychiatr Prax; 2004 Apr; 31(3):147-56. PubMed ID: 15042478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expenditures for members of a health insurance company suffering from alcoholism - a payer's view].
    Stamm K; Merkel S; Mann K; Salize HJ
    Psychiatr Prax; 2007 May; 34(4):194-9. PubMed ID: 17160794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Socioeconomic burden of hip fractures in Germany].
    Weyler EJ; Gandjour A
    Gesundheitswesen; 2007 Nov; 69(11):601-6. PubMed ID: 18080931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].
    Liebl A; Spannheimer A; Reitberger U; Görtz A
    Med Klin (Munich); 2002 Dec; 97(12):713-9. PubMed ID: 12491064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost evaluation of a model for integrated care of seriously mentally ill patients].
    Fischer F; Hoffmann K; Mönter N; Walle M; Beneke R; Negenborn S; Weinmann S; Willich SN; Berghöfer A
    Gesundheitswesen; 2014 Feb; 76(2):86-95. PubMed ID: 23737155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
    Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum WA; Kolb H
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):495-501. PubMed ID: 17853332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Income reduction due to sickness benefits--when does sickness make you poor?].
    Mielck A; Huber CA
    Gesundheitswesen; 2005; 67(8-9):587-93. PubMed ID: 16217712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incremental cost effectiveness of multifocal cataract surgery].
    Pagel N; Dick HB; Krummenauer F
    Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A cost of illness study of diabetes mellitus].
    von Ferber L; Köster I; Hauner H
    Gesundheitswesen; 1997 Jan; 59(1):17-22. PubMed ID: 9138642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded mental health benefits and outpatient depression treatment intensity.
    Lo Sasso AT; Lindrooth RC; Lurie IZ; Lyons JS
    Med Care; 2006 Apr; 44(4):366-72. PubMed ID: 16565638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of type 2 diabetes in Germany. Results of the CODE-2 study].
    Liebl A; Neiss A; Spannheimer A; Reitberger U; Wagner T; Görtz A
    Dtsch Med Wochenschr; 2001 May; 126(20):585-9. PubMed ID: 11402924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
    Stensland MD; Jacobson JG; Nyhuis A
    J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.